CLOV vs VYNE · rev $1.37B vs rev $501.0K
Clover Health Investments Corp (CLOV) versus Vyne Therapeutics Inc (VYNE) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Vyne Therapeutics Inc (VYNE) is a biotechnology company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VYNE revenue for 2024-12-31 was $501.0K. Net income was -$39.8M. Revenue was up 18.2% from 2023-12-31 to 2024-12-31. VYNE currently screens at market cap $21.1M.
CLOV currently screens at market cap $1.55B. VYNE currently screens at market cap $21.1M.
Not investment advice. Open the CLOV and VYNE stock pages for the full models.
Not investment advice.